The Radiotherapy Department of the fourth hospital of Hebei Medical University, founded in 1969, is an early department engaged in tumor radiotherapy in China. After several generations of entrepreneurship, it has become one of the more famous cancer radiotherapy centers in China. At present, it is the key subject of Hebei Education Commission and Hebei health and Health Commission, and one of the strong characteristic subjects of Hebei Colleges and universities. At present, the Department is in the leading position in terms of discipline scale, team strength, technical equipment, academic exchange and scientific and technological achievements, and is the radiotherapy center and training base in Hebei Province and even in the whole North China.
Department scale: at present, there are 5 wards and 1 technical group in the Radiotherapy Department of the fourth hospital of Hebei Medical University. Each ward has 31 beds, which is responsible for the reception, treatment and clinical treatment of tumor patients. The technical group is responsible for the specific radiotherapy work of the patients. At present, there are more than 200 general practitioners, including more than 70 doctors, more than 70 nurses, 10 physicists, more than 70 technicians, and 400-500 inpatients in the department all the year round. In the past 10 years, the expansion of the ward has always maintained a high bed utilization rate, and the economic and social benefits have been steadily improved for many years. It is one of the pillar departments of the hospital.
Department management: radiotherapy is a special discipline. The level of technology depends on the overall level and strength of the team. Because there are many treatment links, problems in each link may affect the treatment effect. Therefore, the Radiotherapy Department of the fourth hospital of Hebei Medical University has developed a complete set of management system. In addition to the medical staff, the Department also put forward higher requirements for the physicists and technicians. In recent years, we have introduced professional physicists and related technical personnel with high education and carried out strict on-the-job training, supplemented and improved the talent team, and ensured the overall strength of the team. Now, the radiotherapy department is a leading department with famous experts as the discipline leader, advanced equipment as the technical guarantee, talent team as the quality guarantee, perfect department management as the system guarantee, courage in innovation and comprehensive development of medical teaching and research.
Technical equipment: since entering the era of precise radiotherapy for tumors in the 21st century, the Department has successively purchased the first Siemens Oncor linear accelerator in Asia, the new principle medical linear accelerator produced by elekda company in Sweden, 23EX medical linear accelerator produced by Varian company in the United States and other medical linear accelerators. In 2011, the Department purchased the image-guided radiotherapy and rapid volume rotation intensity-modulated radiotherapy Volume intensity modulated arc therapy -VMAT) is an integrated medical linear accelerator and treatment planning system. In 2019 and 2020, tomo and CyberKnife will be further introduced into the Department. At present, the Department has 6 imported medical linear accelerators, 1 CT analog positioning machine and 1 digital analog positioning machine, 16 sets of treatment planning system (all of which are Imported TPS, including pinnacle, CMS, normas, nuectron and other global treatment planning systems with the best performance), in addition, it also has complete dose verification facilities, including two-dimensional and three-dimensional dose verification instruments, a set of three-dimensional water tanks, which are sufficient to guarantee the development of advanced and accurate treatment technologies such as three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, image guided + rotary intensity-modulated radiotherapy, It ensures the quality control (QC) and quality assurance (QA) of the most critical links of radiotherapy, and ensures the accuracy and efficacy of patients' treatment. Such technical equipment is in the leading position in all radiotherapy centers in the country.
Team strength: at present, there are more than 40 doctors in the Radiotherapy Department of the fourth hospital of Hebei Medical University, including 2 doctoral supervisors, 15 master supervisors, 16 persons with senior titles, 11 persons with deputy senior titles, 12 persons with doctoral degrees and 47 persons with master's degrees. The discipline has formed a professional team with reasonable structure, high degree, high quality and strong vitality. Professor Han Chun, the discipline leader, has been the director of Radiotherapy Department of the fourth hospital of Hebei Medical University since he returned from Paris 12 university in 2001. So far, he has led the radiotherapy department for more than 10 years and achieved the continuous and stable development of the Department year after year. Professor Han Chun has been engaged in the basic and clinical research of radiation oncology for more than 20 years. His chief editor and co editor's works include radiotherapy of esophageal cancer, esophageal cancer and cardiac cancer, non-surgical treatment of malignant tumor, oncology and tumor radiotherapy (Textbook for the 12th Five Year Plan of general higher education), etc. At present, he has undertaken many provincial and department level projects and published more than 100 academic papers, including more than 10 articles included in SCI, nearly 50 articles in Chinese journals, 3 second prizes and 3 third prizes in Hebei Province for scientific and technological progress, including 2009 series of research on accurate radiotherapy for esophageal cancer and 2014 research on formulation and application of standard for accurate radiotherapy for esophageal cancer He is currently the director of the radiotherapy department and the second ward of the fourth hospital of Hebei Medical University, the director of the radiotherapy teaching and Research Office, the standing member of the radiation tumor branch of the Chinese Medical Association, the standing member of the radiation tumor Professional Committee of the Chinese Anti Cancer Association, the leader of the esophageal cancer group of the radiation tumor branch of the Chinese Medical Association, the former chairman of the radiation tumor branch of the Hebei Medical Association, and the former chairman of the anti cancer branch of Hebei Province Honorary chairman of radiation oncology Committee of cancer association, executive director of Hebei Cancer Association. In 2010, he won the title of "young and middle-aged experts with outstanding contributions" in Hebei Province. In 2016, he won the title of "expert of government special allowance", and is a well-known oncology expert in China. Professor Zhu shuchai, the discipline leader, has been the director of the third ward of Radiotherapy Department of the fourth hospital of Hebei Medical University since 2003. In the past 20 years, Professor Zhu shuchai has always chosen the basic and clinical research of radiotherapy with the focus on esophageal cancer. He has undertaken 2 projects of National Natural Science Foundation, 2 projects of Ministry of education and 2 projects of Hebei Natural Science Foundation. He has published nearly 100 papers, including 6 SCI papers. In 1999 and 2010, the scientific research achievements "the effect of cyclin D1, PCNA protein expression and DNA content on radiotherapy of esophageal cancer" and "the basic research and clinical application of radiation lung injury and esophageal injury" won the second prize of science and technology progress of Hebei Province respectively, "the evidence-based research on CT scanning and internal and external irradiation plus chemotherapy in the treatment of esophageal cancer" and "re evaluation and standardization of esophageal cancer with three-dimensional conformal radiotherapy plan" Preventive radiation field after radical operation was awarded the third prize of Hebei Province in 2001 and 2006 respectively. At present, it is a member of radiation oncology branch of Chinese Medical Association and has a high reputation among peers in China.
Academic exchange: Henan, Linxian, Hebei, Cixian and Shexian County are among the highest incidence rate of esophageal cancer in the world. Radiotherapy is the main treatment for esophageal cancer. The Fourth Department of radiotherapy of Hebei Medical University is the most famous treatment center for esophageal cancer. The Department has held many domestic and provincial seminars on radiotherapy for esophageal cancer. The conferences organized and organized mainly include the National Seminar on brachytherapy for cancer (1995), the second annual conference of Hebei society of radiotherapy (1996), the international seminar on radiotherapy for esophageal cancer (1998), the National Seminar on radiotherapy for esophageal cancer (2000, 2003, 2005) In 2009, 2009, 2011, 2016, etc., through many meetings and discussions, to a certain extent, the development of esophageal cancer radiotherapy specialty was driven. In 2009, the fifth national esophageal cancer radiotherapy seminar passed the "clinical staging of non-surgical treatment of esophageal cancer" standard led by the fourth hospital of Hebei Medical University, which was promoted to the whole country for trial, filling the domestic market There is a big gap in the field of radiotherapy for esophageal cancer, which is of great academic significance. Then, Professor Han Chun devoted himself to the study of the standard of short-term curative effect after radiotherapy of esophageal cancer with CT image, and made up for the shortage of only using esophageal barium meal to evaluate the immediate curative effect of radiotherapy with the advantage of CT, which will fill another research gap in the field of radiotherapy of esophageal cancer in China. In addition, the Department team also actively participated in academic exchanges at home and abroad, and many people made speeches at important academic conferences at home and abroad for many years, greatly improving the influence and status of the Radiotherapy Department of the fourth hospital of Hebei Medical University in the academic community. The American annual conference on Radiation Oncology (ASTRO Conference) is the highest level academic conference in the field of international radiation oncology. Professor Han Chun and Professor Zhu shuchai from the Department of radiotherapy, the fourth hospital of Hebei Medical University have been included in the conference and invited to participate in the conference for many consecutive years, which is of great significance for the exchange between departments and the international community.
Scientific and technological achievements: in recent years, the Radiotherapy Department of the fourth hospital of Hebei Medical University has also made great achievements in scientific and technological achievements. As early as in the 1990s, Professor Han Chun and Professor Zhu shuchai of the Department won the Hebei Medical Science and Technology Progress Award and Hebei Science and Technology Progress Award for many times. Among them, the research on the later course accelerated hyperfractionation radiotherapy of esophageal cancer and the evaluation of the rationality of intraluminal irradiation of esophageal cancer with CT images won the third prize of Hebei Science and Technology Progress Award in 1997, and the expression of cyclin D1 and PCNA protein And the effect of DNA content on radiotherapy of esophageal cancer was awarded the second prize of Hebei Province for scientific and technological progress in 1999. The third prize of Hebei Province for scientific and technological progress was awarded in 2001 and 2006 respectively in "evidence-based research on CT scanning and internal and external radiation plus chemotherapy in the treatment of esophageal cancer" and "reevaluation of standardized preventive radiation field after radical resection of esophageal cancer with three-dimensional conformal radiotherapy plan". In recent years, the scientific research work of radiotherapy has been blooming day by day and has achieved gratifying results year by year. Since 2009, the Department has successively won the science and technology achievement award of Hebei Provincial Department of science and technology. In the past 10 years, it has won one first prize of science and technology progress of Hebei Province, seven second prizes of science and technology progress, and two third prizes of science and technology progress. Such achievements are major breakthroughs in cancer treatment centers of the whole province and even the whole country.
